These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32082246)

  • 1. Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke.
    Tan C; Wang H; Gao X; Xu R; Zeng X; Cui Z; Zhu J; Wu Q; Xia G; Zhou H; He Y; Yin J
    Front Neurol; 2020; 11():29. PubMed ID: 32082246
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Value of Plasma Trimethylamine N-Oxide Levels in Patients with Acute Ischemic Stroke.
    Zhai Q; Wang X; Chen C; Tang Y; Wang Y; Tian J; Zhao Y; Liu X
    Cell Mol Neurobiol; 2019 Nov; 39(8):1201-1206. PubMed ID: 31332666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
    Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.
    Zhang J; Wang L; Cai J; Lei A; Liu C; Lin R; Jia L; Fu Y
    J Neuroimmunol; 2021 May; 354():577526. PubMed ID: 33647820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke.
    Chang L; Yan H; Li H; Song Z; Gui Y; Yan Z; Li T; Duan D
    Neuroreport; 2014 Sep; 25(13):985-90. PubMed ID: 25102374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota-derived metabolite trimethylamine-N-oxide and stroke outcome: a systematic review.
    Zhang P; Wang R; Qu Y; Guo ZN; Yang Y
    Front Mol Neurosci; 2023; 16():1165398. PubMed ID: 37333616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of Trimethylamine-N-oxide in patients with ischemic stroke.
    Rexidamu M; Li H; Jin H; Huang J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142624
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury.
    Wu C; Xue F; Lian Y; Zhang J; Wu D; Xie N; Chang W; Chen F; Wang L; Wei W; Yang K; Zhao W; Wu L; Song H; Ma Q; Ji X
    Neurology; 2020 Feb; 94(7):e667-e677. PubMed ID: 31907287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Biomarkers of Plasma Trimethylamine N-Oxide and Short-Chain Fatty Acids for Recanalization Therapy in Acute Ischemic Stroke.
    Chou PS; Yang IH; Kuo CM; Wu MN; Lin TC; Fong YO; Juan CH; Lai CL
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke.
    Hou L; Zhang Y; Zheng D; Shi H; Zou C; Zhang H; Lu Z; Du H
    Neurol Res; 2020 Feb; 42(2):153-158. PubMed ID: 31928326
    [No Abstract]   [Full Text] [Related]  

  • 11. Utility of Trimethylamine Oxide (TMAO) in Predicting Early Neurological Deterioration after Acute Ischemic Stroke.
    Kang Y; Cheng H; Shi Y; Liu J; Wang Y; Wan D
    J Coll Physicians Surg Pak; 2023 Aug; 33(8):861-865. PubMed ID: 37553923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke.
    Sun T; Zhang Y; Yin J; Peng X; Zhou L; Huang S; Wen Y; Cao B; Chen L; Li X; Yang W; Tan A; Cheng J; Liu L
    J Atheroscler Thromb; 2021 Apr; 28(4):320-328. PubMed ID: 32641646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide.
    Nam HS
    J Stroke; 2019 May; 21(2):151-159. PubMed ID: 31161760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMAO as a Novel Predictor of Major Adverse Vascular Events and Recurrence in Patients with Large Artery Atherosclerotic Ischemic Stroke.
    Chen YY; Ye ZS; Xia NG; Xu Y
    Clin Appl Thromb Hemost; 2022; 28():10760296221090503. PubMed ID: 35345908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin is a novel diagnostic and prognostic marker in patients with ischemic stroke.
    Qi AQ; Li Y; Liu Q; Si JZ; Tang XM; Zhang ZQ; Qi QD; Chen WB
    Free Radic Biol Med; 2015 Mar; 80():129-35. PubMed ID: 25555670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke.
    Uphaus T; Bittner S; Gröschel S; Steffen F; Muthuraman M; Wasser K; Weber-Krüger M; Zipp F; Wachter R; Gröschel K
    Stroke; 2019 Nov; 50(11):3077-3084. PubMed ID: 31537188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
    Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
    J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Troponin I as a Marker for Unfavorable Outcomes in Acute Ischemic Stroke.
    Esteak T; Hasan M; Atiqur Rahman M; Islam DMK; Ray SK; Hosain A; Alam S; Zannat T; Hasan AH; Khan SU
    Cureus; 2023 Nov; 15(11):e49568. PubMed ID: 38156181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
    Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
    J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.